The FDA endorses accelerated approval reforms

The White House budget almost never becomes law, but it does give policy wonks a glimpse of what agencies want from lawmakers. This year, one pitch from regulators caught our attention: The FDA is asking Congress for more authority to crack down on drug makers abusing the so-called accelerated approval pathway.